Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
30. June 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8980
Articles 1 - 20 / 179583
Circulating metabolite biomarkers associated with prostate cancer risk in Black Americans: findings from the Southern Community Cohort Study.
Br J Cancer
Yoon HS, Shu XO, Wu J, Sanderson M, Wang X, Wen W, Courtney R, Yang JJ, Blot WJ, Zheng W, Cai Q.
PMID: 42373845 [PubMed - as supplied by publisher]
Reply to Yue Chang's Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404-12.
Eur Urol Oncol
Contieri R, Hurle R.
PMID: 42373419 [PubMed - as supplied by publisher]
Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis.
Eur Urol
Viti A, Scuderi S, Cucchiara V, Gandaglia G, Briganti A, Montorsi F.
PMID: 42373361 [PubMed - as supplied by publisher]
Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005.
Eur Urol
Takahashi T.
PMID: 42373360 [PubMed - as supplied by publisher]
Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs. Sunitinib) for Advanced Renal Cell Carcinoma.
Anticancer Res
Fujiwara M, Yoshida S, Yajima S, Sato H, Hirakawa A, Fukushima H, Arita Y, Tanaka H, Yokoyama M, Masuda H, Fujii Y.
PMID: 42373289 [PubMed - indexed for MEDLINE]
Insights into Matrix Metalloproteinase-2 Genotypes, Smoking, Alcohol Drinking, Hypertension and Renal Cell Carcinoma in Taiwan.
Anticancer Res
Chang SY, Tsai HW, Wang BR, Yang YC, Chen JC, Tsai CW, Bau DT, Chang WS.
PMID: 42373263 [PubMed - indexed for MEDLINE]
HSP70: From Molecular Chaperone to Integrative Hub in Castration-Resistant Prostate Cancer Therapeutic Resistance.
Eur J Pharmacol
Liu Q, Huang T, Li L, Liang Z, Liu Y, Xiao J, Wang X.
PMID: 42372934 [PubMed - as supplied by publisher]
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.
Lancet Oncol
Francolini G, Di Cataldo V, Caini S, Garlatti P, Aquilano M, Bertini N, Bruni A, Ingrosso G, D'Angelillo RM, Tagliaferri L, Jereczek-Fossa BA, Augugliaro M, Triggiani L, Parisi S, Masieri L, Campi R, Valicenti RK, Simontacchi G, Greto D, Bonomo P, Loi M, Tang C, Livi L, ARTO Working Group.
PMID: 42372744 [PubMed - indexed for MEDLINE]
Establishment of a clear cell renal cell carcinoma organoid cohort integrated into the UroCCR clinical database: A feasibility study.
Transl Oncol
Lefranc R, Waeckel T, Riffet M, Florent R, Desmartin G, Lecouflet L, Divoux J, Poulain L, Tillou X, Weiswald LB, Levallet G, Bazille C.
PMID: 42372405 [PubMed - as supplied by publisher]
Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.
Anticancer Res
Ishikawa G, Tamura K, Watanabe K, Matsushita Y, Watanabe H, Motoyama D, Inamoto T.
PMID: 42373281 [PubMed - indexed for MEDLINE]
Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma.
Anticancer Res
Yen TH, Wang SS, Chen CS, Chen CC, Lin CY, Hung SC, Lai GS, Li JR, Yang CK, Lin YC.
PMID: 42373274 [PubMed - indexed for MEDLINE]
Dual Bipolar Strategy and Postoperative Drain Output in Robot-assisted Radical Nephrectomy.
Anticancer Res
Miyazaki T, Yamazaki F, Fukuhara Y, Iwata A, Sako R, Miyahara T, Noda K, Yokoyama R, Yamashita S, Fujikawa A, Aso S, Aoyagi C, Tachibana M, Tominaga K, Okabe YU, Gunge N, Haga N.
PMID: 42373272 [PubMed - indexed for MEDLINE]
Treatment-Related Cystitis During Intravesical Chemotherapy: Incidence, Risk Factors, And Nursing-Pathway Associations.
J Vis Exp
Zhang J, Wu B, Xie C, Qian X.
PMID: 42372015 [PubMed - indexed for MEDLINE]
Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.
Oncologist
Zugman M, Barata PC.
PMID: 42371793 [PubMed - as supplied by publisher]
Treatment Patterns and Attrition in Metastatic Castration-Resistant Prostate Cancer.
JAMA Netw Open
Hooper G, Jo Y, Nandakumar V, Gebrael G, Ozay ZI, Ostrowski M, Hardy T, Lin E, Campbell P, Murdock EG, Upadhyay L, Goel K, Thomas VM, Li H, Sokolova AO, Swami U, Agarwal N.
PMID: 42371626 [PubMed - indexed for MEDLINE]
Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma.
Cureus
Zamani A, Cohn H, Moser AM, Michael Z, Krinock MJ, Fung G, Shao YF, Ginsburg KB.
PMID: 42371453 [PubMed]
Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies.
Target Oncol
Valikovics AK, Bacsó D, Samaien N, das Virgens IPA, Szentes B, Agócs G, Obeidat M, Széll T, Hadaschik B, Hegyi P, Nyirády P, Szarvas T.
PMID: 42371314 [PubMed - as supplied by publisher]
Diagnostic performance of bpMRI versus mpMRI and AI-assisted bpMRI in prostate cancer detection: a multi-reader study.
Radiol Med
Russo L, Bottazzi S, D'Erme L, Avesani G, Di Paola V, Persiani S, Iacono A, Isufi I, Davies L, Arya Z, Mancino M, Lia F, Pallotta G, Sighinolfi MC, Pierconti F, Rocco B, Sala E, Gui B.
PMID: 42371294 [PubMed - as supplied by publisher]
Targeting macrophage-associated core genes for prognostic prediction and therapeutic insights in bladder cancer.
Discov Oncol
Liu H, Chu Y, Hou J, Wang Y, Li J, Qin J, Liang P, Liao G, Gu P, Liu X, Wen X.
PMID: 42371282 [PubMed - as supplied by publisher]
Imaging response assessment in metastatic renal cell carcinoma: a radiologist's guide to contemporary therapeutic strategies.
Abdom Radiol (NY)
Withey SJ, Caglic I, Ap Dafydd D, Wicki A, Kelly-Morland C, Sohaib A, Sit C, Remer EM, Kekelidze M.
PMID: 42371025 [PubMed - as supplied by publisher]
Articles 1 - 20 / 179583
Page 1 of 8980
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy